MEDINUMB Trademark

Trademark Overview

On Wednesday, September 27, 2017, a trademark application was filed for MEDINUMB with the United States Patent and Trademark Office. The USPTO has given the MEDINUMB trademark a serial number of 87624710. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 20, 2025. This trademark is owned by Tentalle Limited. The MEDINUMB trademark is filed in the Pharmaceutical Products category with the following description:

Anesthetic Numbing Cream
medinumb

General Information

Serial Number87624710
Word MarkMEDINUMB
Filing DateWednesday, September 27, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 20, 2025
Registration Number5623826
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements

Goods and ServicesAnesthetic Numbing Cream

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 20, 2025
Primary Code005
First Use Anywhere DateFriday, October 20, 2017
First Use In Commerce DateFriday, October 20, 2017

Trademark Owner History

Party NameTentalle Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWestern District
HK
Party NameTentalle Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWestern District
HK
Party NameTentalle Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWestern District
HK

Trademark Events

Event DateEvent Description
Thursday, January 4, 2018ASSIGNED TO EXAMINER
Tuesday, October 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 4, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, January 4, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 16, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 4, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, January 4, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, January 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 25, 2018ASSIGNED TO EXAMINER
Friday, September 7, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 7, 2018USE AMENDMENT FILED
Monday, October 1, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 1, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, October 29, 2018ASSIGNED TO EXAMINER
Thursday, November 1, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 2, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Monday, May 13, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 7, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, May 21, 2019REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 20, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

medinumb cream numbing anesthetic